Regeneron Pharmaceuticals (REGN)
Capital Lease Obligations
$0.00
Quarterly · Period ending: · USD
REGN Capital Lease Obligations
Latest reported$0.00period ending
Latest reported$0.00period ending
REGN Quarterly Capital Lease Obligations ($0.00 → $0.00)
Quarterly capital lease obligations
High-resolution chart · PNG
REGN capital lease obligations history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Lease Obligations (USD) |
|---|---|
| 0 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 720,000,000 | |
| 719,700,000 | |
| 719,000,000 | |
| 718,400,000 | |
| 717,800,000 | |
| 717,200,000 | |
| 716,500,000 | |
| 715,900,000 | |
| 715,200,000 | |
| 713,900,000 | |
| 712,700,000 | |
| 711,300,000 | |
| 709,900,000 | |
| 708,500,000 | |
| 707,203,000 | |
| 705,903,000 | |
| 704,645,000 | |
| 703,500,000 | |
| 702,317,000 | |
| 701,173,000 | |
| 707,607,000 | |
| 481,126,000 | |
| 382,228,000 | |
| 361,523,000 | |
| 362,230,000 | |
| 362,919,000 | |
| 364,144,000 | |
| 357,687,000 | |
| 328,394,000 | |
| 310,938,000 | |
| 277,364,000 | |
| 235,585,000 | |
| 204,440,000 | |
| 185,197,000 | |
| 168,013,000 | |
| 165,186,000 | |
| 160,480,000 | |
| 160,810,000 | |
| 160,776,000 | |
| 160,741,000 | |
| 160,627,000 | |
| 160,514,000 | |
| 160,402,000 | |
| 160,334,000 | |
| 160,151,000 | |
| 160,030,000 | |
| 159,016,000 | |
| 157,807,000 | |
| 156,899,000 | |
| 109,022,000 | |
| 62,571,000 | |
| 62,925,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 53,000 | |
| 150,000 | |
| 230,000 |